These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30407690)

  • 21. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
    Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
    Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Filamin A (FLNA) regulates autophagy of bladder carcinoma cell and affects its proliferation, invasion and metastasis.
    Wang Z; Li C; Jiang M; Chen J; Yang M; Pu J
    Int Urol Nephrol; 2018 Feb; 50(2):263-273. PubMed ID: 29288417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
    Jiang W; Zhu D; Wang C; Zhu Y
    Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway.
    Zeng Z; Zhou W; Duan L; Zhang J; Lu X; Jin L; Yu Y
    J Cell Physiol; 2019 Apr; 234(4):3887-3896. PubMed ID: 30146736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
    Wang JF; Gong YQ; He YH; Ying WW; Li XS; Zhou XF; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6605-6615. PubMed ID: 32633349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
    Liu H; Chen D; Bi J; Han J; Yang M; Dong W; Lin T; Huang J
    Aging (Albany NY); 2018 Oct; 10(10):2606-2623. PubMed ID: 30312173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer.
    Lei CY; Wang W; Zhu YT; Fang WY; Tan WL
    Urol Oncol; 2016 May; 34(5):237.e1-10. PubMed ID: 26706119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
    Su H; Tao T; Yang Z; Kang X; Zhang X; Kang D; Wu S; Li C
    Mol Cancer; 2019 Feb; 18(1):27. PubMed ID: 30782157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2.
    Li L; Jiang P; Hu W; Zou F; Li M; Rao T; Ruan Y; Yu W; Ning J; Cheng F
    J Transl Med; 2024 Mar; 22(1):295. PubMed ID: 38515112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B.
    Zhang Q; Wang L; Yu L; Yu Q; Xue L; Shen Z
    Mol Carcinog; 2024 Jun; 63(6):1106-1116. PubMed ID: 38441297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA-135a binding site affects bladder cancer risk.
    Wang W; Yang C; Nie H; Qiu X; Zhang L; Xiao Y; Zhou W; Zeng Q; Zhang X; Wu Y; Liu J; Ying M
    Int J Cancer; 2019 Mar; 144(6):1345-1355. PubMed ID: 30006972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of G2 and S phase-expressed-1 contributes to cell proliferation, migration, and invasion via regulating p53/FoxM1/CCNB1 pathway and predicts poor prognosis in bladder cancer.
    Liu A; Zeng S; Lu X; Xiong Q; Xue Y; Tong L; Xu W; Sun Y; Zhang Z; Xu C
    Int J Biol Macromol; 2019 Feb; 123():322-334. PubMed ID: 30414902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
    Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis.
    Rui X; Wang L; Pan H; Gu T; Shao S; Leng J
    J Cell Mol Med; 2019 Feb; 23(2):865-876. PubMed ID: 30394665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
    Zhong X; Long Z; Wu S; Xiao M; Hu W
    J BUON; 2018; 23(3):776-781. PubMed ID: 30003751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.